LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

91.74 -1.78

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

90.62

Max

93.7

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

1,999

EBITDA

-28M

-110M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+41.19% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.4B

12B

Ankstesnė atidarymo kaina

93.52

Ankstesnė uždarymo kaina

91.74

Naujienos nuotaikos

By Acuity

50%

50%

155 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-02 23:41; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2026-03-02 23:37; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2026-03-02 23:26; UTC

Svarbiausios naujienos

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2026-03-02 22:41; UTC

Rinkos pokalbiai

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2026-03-02 22:32; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-02 22:32; UTC

Rinkos pokalbiai

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2026-03-02 22:21; UTC

Rinkos pokalbiai

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2026-03-02 22:11; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-02 22:11; UTC

Rinkos pokalbiai

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2026-03-02 22:10; UTC

Įsigijimai, susijungimai, perėmimai

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2026-03-02 22:06; UTC

Rinkos pokalbiai

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2026-03-02 22:00; UTC

Rinkos pokalbiai
Uždarbis

Global Forex and Fixed Income Roundup: Market Talk

2026-03-02 22:00; UTC

Rinkos pokalbiai
Uždarbis

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2026-03-02 21:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-02 21:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-02 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-02 21:35; UTC

Įsigijimai, susijungimai, perėmimai

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2026-03-02 21:34; UTC

Įsigijimai, susijungimai, perėmimai

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2026-03-02 21:30; UTC

Įsigijimai, susijungimai, perėmimai

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2026-03-02 21:17; UTC

Svarbiausios naujienos

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2026-03-02 20:44; UTC

Uždarbis

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2026-03-02 20:43; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Treasury Yields Fall, Dollar Strengthens After Attack on Iran -- Market Talk

2026-03-02 20:28; UTC

Uždarbis

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2026-03-02 20:25; UTC

Rinkos pokalbiai
Svarbiausios naujienos

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2026-03-02 20:24; UTC

Uždarbis

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2026-03-02 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2026-03-02 20:12; UTC

Svarbiausios naujienos

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2026-03-02 20:08; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-02 20:08; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2026-03-02 20:05; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

41.19% į viršų

12 mėnesių prognozė

Vidutinis 132.58 USD  41.19%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

20

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

155 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat